Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Pulmonx (LUNG) Long-Term Debt Issuances (2020 - 2023)

Pulmonx has reported Long-Term Debt Issuances over the past 2 years, most recently at $20.0 million for Q1 2023.

Quarterly Long-Term Debt Issuances changed N/A to $20.0 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2023, changed N/A year-over-year, with the annual reading at $20.0 million for FY2023, N/A changed from the prior year.
Long-Term Debt Issuances was $20.0 million for Q1 2023 at Pulmonx, up from $527000.0 in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $20.0 million in Q1 2023 and troughed at -$32.5 million in Q2 2020.